- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07702188
Different Endoscopic Approaches for Sphenoid Sinus
Different Approaches for Sphenoid Sinus
- Identification of the most effective approach for different lesion types
- Correlation between approach and complication rates
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
The sphenoid sinus is one of the most anatomically complex and surgically challenging paranasal sinuses due to its deep location ,wide anatomical variation and proximity to critical neurovascular structures.
Important structures are adjacent to the sphenoid sinus include the dura, pituitary, optic nerve, cavernous sinus, pterygoid canal and nerve, internal carotid artery, and cranial nerves III, IV, VI, V1, V2, which are vulnerable to injury with sphenoid disease.
Wide anatomical variation such as Degree of Pneumatization , Septation Patterns , Sinus Size and Shape, Ostium Location ,Onodi Cells, Prominence or dehiscence of nearby structures.
Therefore, surgeons must carefully select the extent of dissection to create a sphenoid opening that matches the patient's pathology while avoiding the risks associated with overly extensive openings and drilling, which may prolong healing and increase the likelihood of scarring and stenosis.
Diagnostic nasal endoscopy procedures and imaging techniques are of great value for an early and precise diagnosis.
Moreover, endoscopic sinus surgery is a safe and effective technique that allows a direct route to the sphenoid sinus.
Because of its close vicinity to important and vulnerable structures of the skull base, delay in diagnosis and treatment can be potentially lethal.
Sphenoid sinus lesions may range from mild, isolated inflammation to erosive tumors with cranial nerve deficits or cases requiring access to a pneumatized lateral recess .
Additionally, conditions such as tumors, encephaloceles, mucoceles, and skull base lesions demand extra preoperative planning and careful technique selection.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Doaa Araby Mohamed, assistant lecturer
- Telefonnummer: +201119015094
- E-post: DoaaAraby9@aun.edu.eg
Studer Kontakt Backup
- Navn: Ahmed elrahman mohamed azzam, lecturer
- Telefonnummer: 01099978990
- E-post: ahmedazzam@aun.edu.eg
Studiesteder
-
-
-
Asyut, Egypt
- Assiut University hospital
-
Ta kontakt med:
- Doaa Mohamed
- Telefonnummer: 01119015094
- E-post: DoaaAraby9@aun.edu.eg
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Patients with sinonasal lesions involving sphenid sinus with or without skull base extension.
Exclusion Criteria
- Severe comorbidities contraindicating surgery
- malignant tumer extend beyond sphenoid sinus requiring open management
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: endoscopic approaches for sphenoid sinus
type I, sphenoid ostial dilation.
type IIa, transnasal sphenoidotomy (sphenoidotomy without ethmoidectomy).
type IIb, transethmoidal sphenoidotomy (sphenoidotomy with ethmoidectomy).
type III, bilateral, common cavity sphenoidotomy, or "sphenoid drill-out;" type IV, transpterygoid approach, to expose the lateral sphenoid sinus recess.
type V, sphenoid nasalization, completely removing the sphenoid sinus floor.
|
Different approaches include: type I, sphenoid ostial dilation. type IIa, transnasal sphenoidotomy (sphenoidotomy without ethmoidectomy). type IIb, transethmoidal sphenoidotomy (sphenoidotomy with ethmoidectomy). type III, bilateral, common cavity sphenoidotomy, or "sphenoid drill-out;" type IV, transpterygoid approach, to expose the lateral sphenoid sinus recess. type V, sphenoid nasalization, completely removing the sphenoid sinus floor. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
To evaluate different endoscopic surgical approaches to the sphenoid sinus
Tidsramme: 6 months
|
|
6 months
|
|
To evaluate different endoscopic surgical approaches to the sphenoid sinus regarding: * Completence of lesion removal. * Complications. - Csf leakage - Optic nerve injury
Tidsramme: 6 month
|
complications rate (csf leakage , optic nerve injury, carotid artery injury)
|
6 month
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Studieleder: mohamed modather, assistant professor, Assiut University
Publikasjoner og nyttige lenker
Generelle publikasjoner
- https://scholar.google.com/?hl=ar
Hjelpsomme linker
- Castelnuovo, P., Pagella, F., Semino, L., De Bernardi, F., & Delù, G. (2005). Endoscopic treatment of the isolated sphenoid sinus lesions. European Archives of Oto-Rhino-Laryngology and Head & Neck, 262(2), 142-147.
- 3-Jang, J. Y., Kim, G. J., Kim, S. Y., Kim, M. S., Lee, D. K., Kwon, M., ... & Cho, K. J. (2025). Guidelines for the treatment of laryngeal cancer from the Korean society of head and neck surgery. Clinical and experimental otorhinolaryngology, 18(2), 89-
- -Lawson, W., & Reino, A. J. (1997). Isolated sphenoid sinus disease: an analysis of 132 cases. The Laryngoscope, 107(12), 1590-1595..
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- sphenoid sinus approaches
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .